Scopia Capital Management LP Ptc Therapeutics, Inc. Transaction History

Scopia Capital Management LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $28.1 Million - $43.7 Million	-871,780 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$33.82 - $48.17 $3.76 Million - $5.36 Million	-111,225 Reduced 11.31%	871,780 $29.5 Million
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $39.8 Million - $50.5 Million	-1,123,185 Reduced 53.33%	983,005 $44.2 Million
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $13.5 Million - $18.9 Million	479,225 Added 29.46%	2,106,190 $79.3 Million
Q4 2018 Feb 14, 2019	BUY	$29.83 - $46.51 $297,315 - $463,565	9,967 Added 0.62%	1,626,965 $55.8 Million
Q3 2018 Nov 14, 2018	SELL	$33.9 - $47.77 $23.3 Million - $32.8 Million	-686,343 Reduced 29.8%	1,616,998 $76 Million
Q2 2018 Aug 14, 2018	SELL	$25.7 - $47.88 $92.8 Million - $173 Million	-3,610,711 Reduced 61.05%	2,303,341 $77.7 Million
Q1 2018 May 15, 2018	BUY	$17.46 - $32.59 $30.9 Million - $57.7 Million	1,770,782 Added 42.74%	5,914,052 $160 Million
Q4 2017 Feb 14, 2018	BUY	$15.14 - $20.89 $44.6 Million - $61.6 Million	2,949,141 Added 246.97%	4,143,270 $69.1 Million
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $20.1 Million - $25.8 Million	1,194,129	1,194,129 $23.9 Million

223

78M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.3B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Scopia Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Scopia Capital Management LP with notifications on news.